Victory Capital Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-9,496	Closed	-$116K	–	3649
2020 Q1	$116K	Buy	+9,496	New	+$116K	﹤0.01%	2499
2019 Q4	–	Sell	-1,343	Closed	-$16K	–	3620
2019 Q3	$16K	Buy	+1,343	New	+$16K	﹤0.01%	3128